The Lee Silverman Voice Treatment® for voice, speech and other orofacial disorders in patients with Parkinson’s disease

Author： Sapir Shimon   Ramig Lorraine Olson   Fox Cynthia  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.1, Iss.5, 2006-09, pp. : 563-570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Affective disorders in Parkinson’s disease

By Kremer Janus   Starkstein Sergio E.  

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 290-297

Informa Healthcare

Access to resources Recommend Favorite

Anxiety disorders in Parkinson’s disease

By Marsh Laura  

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 307-318

Informa Healthcare

Access to resources Recommend Favorite

Impulse control disorders and cognitive dysfunctions in patients with Parkinson’s disease

By Santangelo Gabriella   Trojano Luigi   Barone Paolo   Grossi Dario   Vitale Carmine  

Neurological Sciences, Vol. 34, Iss. 11, 2013-11 ,pp. : 2045-2046

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence and treatment strategies of dyskinesia in patients with Parkinson’s disease

By Müller T.   Woitalla D.   Russ H.   Hock K.   Haeger D. A.  

Journal of Neural Transmission, Vol. 114, Iss. 8, 2007-08 ,pp. : 1023-1026

Springer Publishing Company

Access to resources Recommend Favorite

Apathy in patients with Parkinson’s disease

By Shulman Lisa M.  

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 298-306

Informa Healthcare

Access to resources Recommend Favorite